Reprint of Classification and pharmacology of progestins-Reference-Cited by-同舟云学术

Reprint of Classification and pharmacology of progestins

Published:2008-09 Issue:1-2 Volume:61 Page:171-180
ISSN:0378-5122
Container-title:Maturitas
language:en
Short-container-title:Maturitas

Author:

Schindler Adolf E.,Campagnoli Carlo,Druckmann René,Huber Johannes,Pasqualini Jorge R.,Schweppe Karl W.,Thijssen Jos H.H.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,General Biochemistry, Genetics and Molecular Biology

Reference20 articles.

1. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women, heart/estrogen-replacement-study (HERS I) group;Hulley;JAMA,1998

2. Cardiovascular disease outcomes during 6.8 years of hormone replacement therapy. Heart estrogen/progestin replacement study follow-up (HERS II);Grady;JAMA,2002

3. Noncardiovascular disease outcomes during 6.8 years of hormone therapy;Hulley;Heart estrogen/progestin replacement study follow-up (HERS II). JAMA,2002

4. Writing Group for the Women's Health Initiative Investigators Risks and Benefits of Estrogen plus Progestin in Healthy Postmenopausal Women. JAMA 2002; 288:321–33.

5. Million women collaborators. Breast cancer and hormone-replacement therapy in the million-women-study. Lancet 2003; 362:419–27.

Cited by 179 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Luteal phase support with oral progesterone improves live birth rate in intrauterine insemination cycles using letrozole;Reproductive BioMedicine Online;2024-10

2. Ultra-low-dose estradiol and dydrogesterone for treatment of vasomotor symptoms in Europe and China;Climacteric;2024-07-30

3. The intersection between menopause and depression: overview of research using animal models;Frontiers in Psychiatry;2024-07-15

4. Inhibition ratio (I.R.) and transformation index (T.I.): new indexes to compare the effectiveness and clinical behaviour of modern progestin-only pills (POP);The European Journal of Contraception & Reproductive Health Care;2024-07-11

5. Ultra-low-dose continuous combined estradiol and dydrogesterone in postmenopausal women: A pooled safety and tolerability analysis;Gynecological Endocrinology;2024-07-08